Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8802129 Methods for treating retinopathy with extended therapeutic effect

Patent 8802129 was granted and assigned to Allergan, Inc. on August, 2014 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 28 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 28 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12071476 IL-6 antibodies and fusion constructs and conjugates thereof
0
Edits on 2 Mar, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 2 Mar, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11912784 Methods of treating an eye disorder
0
Edits on 25 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 25 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=0880212900
Edits on 23 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 23 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 08802129 Methods for treating retinopathy with extended therapeutic effect US Patent 8802129 Methods for treating retinopathy with extended therapeutic effect

Infobox
Patent Number
0880212900
Patent Number
880212900
Edits on 3 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 3 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Allergan, Inc.
Allergan, Inc.
0
Current Assignee
Allergan, Inc.
Allergan, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
088021290
Date of Patent
August 12, 2014
0
Patent Application Number
139462940
Date Filed
July 19, 2013
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=088021290
Patent Primary Examiner
‌
Robert A Wax
0
Edits on 24 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Allergan, Inc.
Allergan, Inc.
0
Current Assignee
Allergan, Inc.
Allergan, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
088021290
Date of Patent
August 12, 2014
0
Patent Application Number
139462940
Date Filed
July 19, 2013
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=088021290
Patent Primary Examiner
‌
Robert A Wax
0
Edits on 19 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 19 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=08802129
Edits on 24 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 24 Dec, 2021
Edits made to:
Infobox (+9 properties)
‌

 US Patent 08802129 Methods for treating retinopathy with extended therapeutic effect

Infobox
Is a
Patent
Patent
Patent applicant
Allergan, Inc.
Allergan, Inc.
Current assignee
Allergan, Inc.
Allergan, Inc.
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
08802129
Date of patent
August 12, 2014
Patent application number
13946294
Date Filed
July 19, 2013
Patent primary examiner
‌
Robert A Wax

Find more entities like US Patent 8802129 Methods for treating retinopathy with extended therapeutic effect

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo